H2AJ and glioblastoma: Furthermore, the transcriptional profiling revealed that the expression of H2AFJ in GBM, grade IV glioma and recurrent tumors is more abundant than that in LGG, grade II/III glioma and primary tumors, respectively, in TCGA LGG/GBM database (Figure 2C).